Metabolism and pharmacokinetics of radium-223 in prostate cancer

Expert Opinion on Drug Metabolism & Toxicology
Oladapo Yeku, Susan F Slovin

Abstract

Prostate cancer metastatic to bone is a cause of significant morbidity and mortality. Bone pain and other skeletal events negatively impact the quality of life in patients who might otherwise be functioning well. As such, there has been intense interest in the development of strategies and pharmaceuticals to address this problem. The authors reviewed the current literature for articles relevant to metastatic prostate cancer, clinical radiopharmaceuticals, castrate-resistant prostate cancer and development of Radium-223 . The authors have referenced primary literature, clinical trials and relevant review articles that summarize the history, development and current utilization of radiopharmaceuticals for management of bone metastases from prostate cancer. Radium-223 is the first radiopharmaceutical with an overall survival benefit approved for the treatment of patients with castration-resistant prostate cancer, symptomatic bone metastasis and no known visceral metastatic disease. The additional benefit of clinically significant improved overall survival should lead to exploration of whether this agent can be used earlier in the treatment algorithm or combined with chemotherapy or androgen deprivation therapy. An individualized ap...Continue Reading

References

May 1, 1992·Clinical Oncology : a Journal of the Royal College of Radiologists·T F SandemanJ J Martin
Sep 1, 1991·The British Journal of Radiology·A H LaingM A Zivanovic
Mar 1, 1989·Radiographics : a Review Publication of the Radiological Society of North America, Inc·R G RobinsonD M Ackery
Jan 1, 1986·European Journal of Nuclear Medicine·G M BlakeD M Ackery
Apr 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M J MooreJ Wilson
Apr 1, 1994·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·P M QuiltyJ Yardley
Jun 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·I F TannockK C Murphy
Apr 29, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A N SerafiniK A Harrison
Aug 24, 1999·Cancer Metastasis Reviews·P H Lange, R L Vessella
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P W KantoffN J Vogelzang
Jun 3, 2000·Human Pathology·L BubendorfM J Mihatsch
Jul 23, 2003·International Journal of Radiation Oncology, Biology, Physics·Sigbjørn SmelandSophie Dorothea Fosså
Apr 16, 2004·The New England Journal of Medicine·G David Roodman
May 12, 2004·Urology·Oliver SartorUNKNOWN Quadramet 424Sm10/11 Study Group
Jun 17, 2004·Palliative Medicine·Catherine Urch
Oct 8, 2004·The New England Journal of Medicine·Ian F TannockUNKNOWN TAX 327 Investigators
Oct 8, 2004·The New England Journal of Medicine·Daniel P PetrylakE David Crawford
Jun 1, 2005·The Lancet Oncology·Ilora G FinlayMike Shelley
Jun 17, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sten NilssonOyvind S Bruland
Oct 26, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Robert E Coleman
Oct 28, 2006·Molecular Endocrinology·Gregory A ClinesTheresa A Guise
Jul 24, 2007·The Journal of Urology·Matthew R CooperbergPeter R Carroll
Dec 12, 2007·Cancer Metastasis Reviews·Karen M BussardAndrea M Mastro
Mar 7, 2008·Expert Reviews in Molecular Medicine·Gregory A Clines, Theresa A Guise
Apr 15, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael J MorrisHoward I Scher
Apr 15, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Karim FizaziAgnes Laplanche
Nov 30, 2010·Seminars in Oncology·Theresa Guise
Oct 12, 2012·European Journal of Nuclear Medicine and Molecular Imaging·Michael Lassmann, Dietmar Nosske
Jul 19, 2013·The New England Journal of Medicine·C ParkerUNKNOWN ALSYMPCA Investigators
Sep 10, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ethan BaschKatherine S Virgo
Sep 17, 2014·Clinical & Experimental Metastasis·Yu ZhengMarkus J Seibel
Oct 2, 2014·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·M S BroderY Linhares
Oct 15, 2014·Prostate Cancer and Prostatic Diseases·A PatrikidouK Fizazi
Dec 3, 2014·The Journal of Urology·Michael S CooksonAdam S Kibel

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Seminars in Nuclear Medicine
Alain S Abi-GhanemHeather A Jacene
Hospital Medicine
M Radford, C L M H Gibbons
Nihon rinsho. Japanese journal of clinical medicine
Katsumasa NakamuraHiroshi Honda
Current Opinion in Supportive and Palliative Care
Salil VengalilChristopher C Parker
© 2022 Meta ULC. All rights reserved